Results

Total Results: 189 records

Showing results for "death".

21. Toc-Intro
    meps.ahrq.gov/data_files/publications/rf19/toc-intro.txt
    January 01, 2010 - Doctoral Candidate, University of Massachusetts Introduction Injuries are the fifth leading cause of death … in the United States (Hoyert, Arias, Smith, et al., 2001) and the leading cause of death for people

22. STATISTICAL BRIEF #526: Health Care Use and Expenditures for Influenza, 2016-17
    meps.ahrq.gov/data_files/publications/st526/stat526.shtml
    October 01, 2019 - Severe flu may result in hospitalizations and even death.

23. Synthesis of "Statistical Innovations for Cost-Effectiveness Analysis" (pdf file)
    meps.ahrq.gov/data_files/publications/workingpapers/wp_08002.pdf
    January 01, 2008 - health care intervention is much broader than simply treating the disease condition or preventing death … Perfect health has a quality weight of 1, while death (or states judged equivalent to death), get a … The ending state is usually death or some other terminal state which ends the evolution of the patient's … implantable cardioverter defibrillator therapy versus drug therapy for patients at high risk of sudden cardiac … death.

24. AHRQ Statistical Brief 526 (pdf file)
    meps.ahrq.gov/data_files/publications/st526/stat526.pdf
    October 01, 2019 - Severe flu may result in hospitalizations and even death.

25. Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020–2021, by Socioeconomic Characteristics
    meps.ahrq.gov/data_files/publications/st551/stat551.shtml
    September 01, 2023 - .01 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020–2021, by Socioeconomic Characteristics   Skip to main content …

26. Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020–2021, by Socioeconomic Characteristics (pdf file)
    meps.ahrq.gov/data_files/publications/st551/stat551.pdf
    September 20, 2023 - Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020–2021, by Socioeconomic Characteristics September 2023 Any Use and "Frequent Use" of Opioids among Adults Aged 65 and Older in 2020–2021, by Socioeconomic Characteristics Asako S. Moriya, PhD and Zhengyi Fang, MS Highlights  In 2020–…

27. Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018–2019, by Socioeconomic Characteristics (pdf file)
    meps.ahrq.gov/data_files/publications/st541/stat541.pdf
    March 01, 2022 - Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018–2019, by Socioeconomic Characteristics March 2022 Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018–2019, by Socioeconomic Characteristics Asako S. Moriya, PhD and Zhengyi Fang, MS Introduction Prescription opioids h…

28. Any Use and "Frequent Use" of Opioids among Non-Elderly Adults in 2018–2019, by Socioeconomic Characteristics (pdf file)
    meps.ahrq.gov/data_files/publications/st542/stat542.pdf
    March 01, 2022 - Any Use and "Frequent Use" of Opioids among Non-Elderly Adults in 2018–2019, by Socioeconomic Characteristics March 2022 Any Use and "Frequent Use" of Opioids among Non-Elderly Adults in 2018–2019, by Socioeconomic Characteristics Asako S. Moriya, PhD and Zhengyi Fang, MS Introduction Prescription opi…

29. Any Use and "Frequent Use" of Opioids among Adults Aged 18-64 in 2020-2021, by Socioeconomic Characteristics
    meps.ahrq.gov/data_files/publications/st552/stat552.shtml
    September 01, 2023 - .01 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd"> Any Use and "Frequent Use" of Opioids among Adults Aged 18-64 in 2020-2021, by Socioeconomic Characteristics   Skip to main content …

30. Any Use and "Frequent Use" of Opioids among Adults Aged 18-64 in 2020-2021, by Socioeconomic Characteristics (pdf file)
    meps.ahrq.gov/data_files/publications/st552/stat552.pdf
    September 20, 2023 - Any Use and "Frequent Use" of Opioids among Adults Aged 18-64 in 2020-2021, by Socioeconomic Characteristics September 2023 Any Use and "Frequent Use" of Opioids among Adults Aged 18– 64 in 2020–2021, by Socioeconomic Characteristics Asako S. Moriya, PhD and Zhengyi Fang, MS Highlights  In 2020–2021,…

31. STATISTICAL BRIEF #531: Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2017
    meps.ahrq.gov/data_files/publications/st531/stat531.shtml
    July 01, 2020 - STATISTICAL BRIEF #531: Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2017   Skip to main content An official website of the Department…

32. Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2017 (pdf file)
    meps.ahrq.gov/data_files/publications/st531/stat531.pdf
    July 01, 2020 - Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2017 July 2020 Healthcare Expenditures for Heart Disease among Adults Age 18 and Older in the U.S. Civilian Noninstitutionalized Po…

33. STATISTICAL BRIEF #139: Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997-2003
    meps.ahrq.gov/data_files/publications/st139/stat139.shtml
    September 01, 2006 - Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase

34. Statistical Brief #139: Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997–2003 (pdf file)
    meps.ahrq.gov/data_files/publications/st139/stat139.pdf
    September 01, 2006 - Risk of acute myocardial infarction and sudden cardiac death in patients oxygenase 2 selective and non-selective

35. STATISTICAL BRIEF #139: Trends in the Use and Expenditures for COX-2 Inhibitors and Traditional Nonsteroidal Anti-inflammatory Drugs, 1997-2003
    meps.ahrq.gov/data_files/publications/st139/draft/stat139.shtml
    September 01, 2006 - Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclooxygenase

36. Sb139
    meps.ahrq.gov/data_files/publications/st139/sb139.xml
    September 01, 2006 - Risk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase

37. Pmed (pdf file)
    meps.ahrq.gov/data_stats/nhc/pmed.pdf
    September 30, 1997 - If Round 1 or Round 2 and the SP is deceased, set {REFERENCE END DATE} to the {MONTH OF DATE OF DEATH … If Round 3 and SP is deceased, set {REFERENCE END DATE} to {MONTH OF DATE OF DEATH} or "December", whichever … In R1 or R2, if the month of {DATE OF DEATH} or {DATE OF DISCHARGE} is unknown, set {REFERENCE END DATE … In R3, if the month of {DATE OF DEATH} or {DATE OF DISCHARGE} is unknown, set {REFERENCE END DATE} to

38. Healthcare Expenditures for Heart Disease among Adults Aged 18 and Older in the U.S. Civilian Noninstitutionalized Population, 2020 (pdf file)
    meps.ahrq.gov/data_files/publications/st550/stat550.pdf
    September 01, 2023 - The Leading Causes of Death in the US for 2020.

39. Any Use and "Frequent Use" of Opioids among Elderly Adults in 2018-2019, by Socioeconomic Characteristics
    meps.ahrq.gov/data_files/publications/st550/stat550.shtml
    September 01, 2023 - The Leading Causes of Death in the US for 2020 .

40. AHRQ Statistical Brief
    meps.ahrq.gov/data_files/publications/st318/sb318_pdf_right.html
    March 01, 2011 - date earlier in the year when they were last considered to be in-scope for the survey (e.g., before death